Bakkt (BKKT) Is Up 9.1% After Zoth Taps It For Regulated Cross‑Border Stablecoin Payments

  • Earlier in May 2026, Zoth announced it had signed a memorandum of understanding with Bakkt, Inc., using Bakkt’s licensed subsidiary Bakkt Financial Solutions I, LLC to underpin a planned cross‑border payments offering that combines Bakkt’s US regulatory infrastructure with Zoth’s emerging‑market payment corridors and local operations.
  • The arrangement positions Bakkt as the regulated backbone for Zoth’s enterprise money transfer clients, potentially enhancing Bakkt’s role in compliant, institutional‑grade stablecoin payment flows across high‑growth regions.
  • We’ll now examine how Bakkt’s role as Zoth’s regulated infrastructure partner could influence the company’s broader investment narrative and future opportunities.

Find 54 companies with promising cash flow potential yet trading below their fair value.

Advertisement

Bakkt Investment Narrative Recap

To own Bakkt, you need to believe it can turn its regulated crypto and stablecoin infrastructure into sustainable, higher margin fee revenue, despite current losses and past volatility. The Zoth partnership and new Zoth powered corridors speak directly to the core near term catalyst around Bakkt Agent transaction growth, while the fresh US$208.4 million shelf registration and widening losses keep dilution risk and balance sheet pressure front and center for the short term.

The most directly connected update here is Bakkt’s Q1 2026 result, which swung from a US$7.7 million profit a year ago to an US$11.7 million net loss, underscoring how far the business still is from consistent profitability even as it signs new Agent and Markets partnerships. Against that backdrop, the Zoth MOU matters because it could test whether Bakkt’s licensed infrastructure can actually convert these early corridor wins into recurring, fee based cross border volumes.

Yet behind the appeal of new cross border stablecoin flows, investors should be aware that ongoing equity issuance and limited cash runway could...

Read the full narrative on Bakkt (it's free!)

Bakkt's narrative projects $207.9 million revenue and $49.0 million earnings by 2028. This assumes revenue will decrease by 62.3% per year and a $90.5 million earnings improvement from -$41.5 million today.

Uncover how Bakkt's forecasts yield a $40.00 fair value, a 313% upside to its current price.

Exploring Other Perspectives

BKKT 1-Year Stock Price Chart
BKKT 1-Year Stock Price Chart

Eight fair value estimates from the Simply Wall St Community span roughly US$11 to more than US$298,000 per share, showing just how far opinions can diverge. Set against that spread, the recent swing back to losses and reliance on equity issuance highlight how sensitive Bakkt’s future performance may be to whether Agent and Markets volumes scale fast enough, so it makes sense to compare several of these viewpoints before forming your own view.

Explore 8 other fair value estimates on Bakkt - why the stock might be worth just $11.50!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Bakkt research is our analysis highlighting 4 important warning signs that could impact your investment decision.
  • Our free Bakkt research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Bakkt's overall financial health at a glance.

Ready For A Different Approach?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Bakkt might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:BKKT

Bakkt

Engages in digital building financial infrastructure business.

Excellent balance sheet with low risk.

Advertisement

Weekly Picks

CE
Ceazar
CNXU logo
Ceazar on Conexeu Sciences ·

This small biotech is developing technology that could potentially change how tissue is rebuilt

Fair Value:US$25.3450.6% undervalued
17 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
HE
HedgeY
PWR logo
HedgeY on Quanta Services ·

The Picks-and-Shovels Leader of the Grid Supercycle

Fair Value:US$7101.3% overvalued
32 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
FU
KRMN logo
FundamentalFlow on Karman Holdings ·

KRMN — Karman Space & Defense: Down 58% from Peak, Is the Market Mispricing a Hypergrowth Defense Compounder?

Fair Value:US$105.651.0% undervalued
16 users have followed this narrative
1 users have commented on this narrative
9 users have liked this narrative
DO
Double_Bubbler
IES logo
Double_Bubbler on Invinity Energy Systems ·

Invinity Energy Systems: All About That BESS

Fair Value:UK£163.7% undervalued
20 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative

Updated Narratives

RO
RockeTeller
LIO logo
RockeTeller on Lion One Metals ·

Lion One Metals, Fiji Gold Turnaround & 30k+ oz Production Potential 2027

Fair Value:CA$395.3% undervalued
7 users have followed this narrative
2 users have commented on this narrative
1 users have liked this narrative
AN
AnimalDoctorKwon
SPRY logo
AnimalDoctorKwon on ARS Pharmaceuticals ·

Why the Market is Wrong About the ARS Pharma vs. Aquestive "DUOPOLY"

Fair Value:US$27.7365.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
AnimalDoctorKwon
INMD logo
AnimalDoctorKwon on InMode ·

A Clear Case of Mispricing.

Fair Value:US$21.6937.8% undervalued
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7444.1% undervalued
66 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9635.2% undervalued
56 users have followed this narrative
8 users have commented on this narrative
17 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1928.3% undervalued
51 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative